Intervertebral disc degeneration, inflammation, and bioactive lipids
Recent Trends in Pharmacology · 2024
DOI: 10.62425/rtpharma.1589019 ↗At a glance
Journal article in Recent Trends in Pharmacology, 2024. Written by Undurti Das and 1 co-authors. 22 references.
Abstract (original language)
Intervertebral disc degeneration, inflammation, and bioactive lipids Intervertebral disc degeneration Intervertebral disc (IVD) degeneration is a common condition that is associated with significant morbidity. There is no specific treatment available for IVD except for surgical intervention. IVD is an inflammatory condition. I propose that IVD can be prevented and managed by local administration of lipoxin A4 (LXA4), a potent anti-inflammatory, cytoprotective and anti-osteoporotic metabolite formed from arachidonic acid (AA). Keywords: intervertebral disc, degeneration, lipoxin A4, arachidonic acid, inflammation.
Cite
APA
Das, U., & Hacımüftüoğlu, A. (2024). Intervertebral disc degeneration, inflammation, and bioactive lipids. Recent Trends in Pharmacology. https://doi.org/10.62425/rtpharma.1589019
Vancouver
Das U, Hacımüftüoğlu A. Intervertebral disc degeneration, inflammation, and bioactive lipids. Recent Trends in Pharmacology. 2024. doi:10.62425/rtpharma.1589019
BibTeX
@article{Das2024,
author = {Das, Undurti and Hacımüftüoğlu, Ahmet},
title = {Intervertebral disc degeneration, inflammation, and bioactive lipids},
journal = {Recent Trends in Pharmacology},
year = {2024},
doi = {10.62425/rtpharma.1589019}
}
EUVIMED